[Transcatheter treatment of patent ductus arteriosus].
Isolated patent ductus arteriosus accounts for 10 to 18% of all cardiovascular malformations. Transcatheter closure of the patent ductus arteriosus has now become established practice with a high success rate and a low incidence of complications. Many devices have been proposed during the last 20 years. The use of some of these devices has largely been abandoned for different reasons: high costs, the need of large transvenous sheaths and the high incidence of late residual shunts. The devices currently available (Amplatzer duct occluder, buttoned device, DuctOcclud coil, Gianturco-Grifka vascular occlusion device, detachable coils) render the embolization of a patent ductus arteriosus relatively easy, with a short hospital stay. We feel that this is the treatment of choice for the majority of patients with a patent ductus arteriosus. The aim of this article was to review our experience and report the state-of-the-art in transcatheter patent ductus arteriosus therapy.
Chessa
Massimo
M
Cardiologia Pediatrica Istituto Policlinico San Donato Via Morandi, 30 20097 San Donato Milanese, MI. massimo.chessa@lycos.com
Mohamed
Bamoshmoosh
B
Giusti
Sandra
S
Butera
Gianfranco
G
Bini
Roberta Margherita
RM
Carano
Nicola
N
Agnetti
Aldo
A
Squarcia
Umberto
U
Di Gregorio
Giovanna
G
Carminati
Mario
M
D021721:Balloon Occlusion / Q000295:instrumentation / Q000379:methods; D004374:Ductus Arteriosus, Patent / Q000628:therapy*; D006801:Humans; D012189:Retrospective Studies; D016896:Treatment Outcome